Related Experiment Video
Updated: Sep 13, 2025

Author Spotlight: Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
Published on: February 24, 2023
CD142-positive synovial fibroblasts drive meniscus destruction in rheumatoid arthritis
Hao Sun1, Xiaobin Lin1, Fangzhou Liu1
1Department of Joint Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Abstract:
Previous evidence suggest bone and cartilage damage is the main pathogenesis of rheumatoid arthritis joint destruction. However, the role of meniscus usually has not been thoroughly explored. Here, we identify CD142+ synovial fibroblasts as a subset located at sublining layer in normal and osteoarthritis synovium, which is increased and distributed at lining layer in rheumatoid arthritis synovium. Injection of CD142+ fibroblasts into DBA/1 male mice's knee destructs meniscus but has slight effect on cartilage. ABCC4 is highly expressed in CD142+ fibroblasts, whose blockage by MK571 attenuates CD142+ fibroblasts-induced meniscus destruction through cAMP/PKA signaling. Long-term follow-up of rheumatoid arthritis cohort indicates that enriched CD142+ fibroblasts at lining layer are a risk factor for severe knee joint destruction and eventually undergo total knee arthroplasty. Our results demonstrate CD142+ fibroblasts as an indicator to assess prognosis and a therapeutic target to inhibit meniscal destruction, thereby alleviating rheumatoid arthritis knee joint damage.
Insights
CD142+ fibroblasts in rheumatoid arthritis synovium drive meniscus destruction. Blocking ABCC4 with MK571 inhibits this damage, offering a new therapeutic target for knee joint preservation.
Area of Science:
- Rheumatology
- Cell Biology
- Immunology
Background:
- Rheumatoid arthritis (RA) primarily affects joints, with bone and cartilage damage being key features.
- The role of the meniscus in RA pathogenesis has been under-explored.
- Synovial fibroblasts are implicated in joint inflammation and destruction.
Purpose of the Study:
- To investigate the role of CD142+ synovial fibroblasts in rheumatoid arthritis (RA) joint destruction.
- To identify the mechanisms underlying CD142+ fibroblast-mediated meniscus damage.
- To evaluate CD142+ fibroblasts as a prognostic indicator and therapeutic target in RA.
Main Methods:
- Identification and characterization of CD142+ fibroblasts in normal, osteoarthritis, and rheumatoid arthritis synovium.
- In vivo experiments injecting CD142+ fibroblasts into mouse knees.
- Pharmacological inhibition of ABCC4 using MK571.
- Analysis of cAMP/PKA signaling pathways.
- Long-term follow-up of an RA patient cohort.
Main Results:
- CD142+ fibroblasts are increased and located at the lining layer in RA synovium.
- Injection of CD142+ fibroblasts into mouse knees caused significant meniscus destruction.
- ABCC4 is highly expressed in CD142+ fibroblasts; its blockage attenuated meniscus destruction via cAMP/PKA signaling.
- Enriched CD142+ fibroblasts in RA patients correlated with severe knee destruction and need for total knee arthroplasty.
Conclusions:
- CD142+ synovial fibroblasts are a key driver of meniscus destruction in rheumatoid arthritis.
- Targeting ABCC4 in CD142+ fibroblasts presents a potential therapeutic strategy to prevent RA-induced knee damage.
- CD142+ fibroblasts serve as a valuable prognostic biomarker for severe joint destruction in RA.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Rheumatic Heart Disease I: Introduction
The JAK-STAT Signaling Pathway

